Matches in Wikidata for { <http://www.wikidata.org/entity/Q65384528> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65384528 description "clinical trial" @default.
- Q65384528 description "ensayu clínicu" @default.
- Q65384528 description "klinisch onderzoek" @default.
- Q65384528 description "клінічне випробування" @default.
- Q65384528 name "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia" @default.
- Q65384528 name "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia" @default.
- Q65384528 type Item @default.
- Q65384528 label "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia" @default.
- Q65384528 label "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia" @default.
- Q65384528 prefLabel "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia" @default.
- Q65384528 prefLabel "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia" @default.
- Q65384528 P1132 Q65384528-3F7B7B2F-2F7C-4D76-8189-3EC509AD9DB7 @default.
- Q65384528 P1476 Q65384528-8C2E0DCB-ABAD-47B6-AB8C-420913BED6AF @default.
- Q65384528 P17 Q65384528-00E1667C-D41A-4B57-A001-556DD9AE87EA @default.
- Q65384528 P2899 Q65384528-408200FE-4B7A-401C-BDE8-F8EDB6DB1462 @default.
- Q65384528 P3098 Q65384528-C506791E-D94A-4A1C-9127-019AAEC7E1EA @default.
- Q65384528 P31 Q65384528-4DE9945C-F1EA-479E-89CF-10F2528CFEBB @default.
- Q65384528 P4135 Q65384528-43CF39B8-9D06-46D8-9584-23445D0AB0F2 @default.
- Q65384528 P580 Q65384528-51DE07D6-1B41-44D3-AACB-89120AF65BD0 @default.
- Q65384528 P582 Q65384528-C2B81BD9-EA09-4D7F-8888-9B38251CE34D @default.
- Q65384528 P6099 Q65384528-05EF4D39-E15C-4C08-893F-E3064EC5707D @default.
- Q65384528 P6153 Q65384528-1DD66358-F69D-4D15-8225-09FAAB8B8616 @default.
- Q65384528 P6153 Q65384528-651AC63E-DD4C-4431-BBD6-88C9246B7693 @default.
- Q65384528 P6153 Q65384528-FB8E63D7-EBE6-42E6-B4D7-3E7D71FFA62C @default.
- Q65384528 P8363 Q65384528-A8B09AD1-F6CF-42D4-A2F8-A315E511B424 @default.
- Q65384528 P921 Q65384528-5B031243-6999-4F8A-9954-6E61B9586AFB @default.
- Q65384528 P1132 "+481" @default.
- Q65384528 P1476 "A Multi-Center, Prospective, Longitudinal, Randomized, Double-Blind, Phase III Study to Evaluate the Efficacy and Safety of Daily Administration of Pravastatin 40 mg or Fenofibrate 160 mg or Pravafen (the Combination of Pravastatin and Fenofibrate 40/160 mg) for 12 Weeks Followed by a 52-Week Open-Label Safety Phase of the Pravafen Alone in the Treatment of Combined Hyperlipidemia." @default.
- Q65384528 P17 Q30 @default.
- Q65384528 P2899 "+18" @default.
- Q65384528 P3098 "NCT00459745" @default.
- Q65384528 P31 Q30612 @default.
- Q65384528 P4135 "+75" @default.
- Q65384528 P580 "2007-04-01T00:00:00Z" @default.
- Q65384528 P582 "2008-04-01T00:00:00Z" @default.
- Q65384528 P6099 Q42824827 @default.
- Q65384528 P6153 Q30269696 @default.
- Q65384528 P6153 Q30282299 @default.
- Q65384528 P6153 Q30289162 @default.
- Q65384528 P8363 Q78089383 @default.
- Q65384528 P921 Q419724 @default.